Board of Directors
James R. Leininger, M.D.
Dr. Leininger has been a founder and investor in more than 40 companies. He has founded and established numerous healthcare companies through or with his private equity team. These include companies in the healthcare services sector (an ambulatory services company partnering with physicians and providing dialysis and radiation oncology services; an outpatient imaging services and management company), the medical technology sector (a medical device company with two CE Marks-approved devices and one FDA-approved device; a company developing a device to treat glaucoma and presbyopia), a medical diagnostic company utilizing a novel technology to identify malignant lesions, and a medical diagnostic company to help detect and alert individuals experiencing seizures), the healthcare information technology sector (a physician practice software company focused on women’s health; an early stage healthcare informatics company creating electronic medical records for Regional Health Information Organizations (RHIOs), large healthcare systems, hospitals and multisite practices; a benefits management company utilizing proprietary software), and the pharmaceutical sector.
Chris Fashek is an accomplished healthcare executive with a winning record of leading billion dollar global medical-device and pharmaceutical businesses.
An inspirational leader who creates a shared vision and actively contributes to ensure the achievement of goals and objectives. Known for developing highly productive/profitable leadership teams and corporate cultures, Mr. Fashek has mastered the full-product life cycle, taking multiple healthcare products from idealization to commercialization; as well as turning-around under-performing corporations to profitability. He is recognized globally as an achiever, strategic thinker and solid decision maker and has developed an influential network of industry partners resulting in new business opportunities and bottom-line growth.
Prior to Brain Sentinel, Chris was the CEO of Atteris Healthcare, LLC and Vice Chairman of Rochal Industries LLC bringing innovative technologies to patients, clinicians, and providers. Its area of focus will be Advanced Wound Care and skin-healing products. Chris was Chairman of the Board of Systagenix, CEO and Chairman of Spiracur, Inc., and the former Vice Chairman and President of KCI USA.
Chris serves on the boards of NanoVibronix, as Chairman, Rochal Industries LLC, as Vice Chairman, World Craniofacial Foundation (WCF), and IDN Summit. He is a subject matter expert in business development, marketing, sales, product development and positioning corporations for hyper-growth and sustainability. He holds his MBA from Fairleigh Dickinson University and Bachelor of Arts in History from Upsala College.
Gerhard Bette is a Senior Partner Emeritus of McKinsey & Company, Inc., the global consulting firm. He retired from McKinsey’s Chicago office at the end of October 2010 after more than 28 years serving leading global institutions on some of their most important issues. His practice focused on working with senior teams of technology-based companies in healthcare, IT and telecommunications industries. He has also worked with several leading Private Equity firms on due diligence efforts and portfolio company management issues. At McKinsey, Mr. Bette held a range of internal leadership roles. He is one of the co-founders of McKinsey’s global Telecommunication practice and served as the leaders of its North American telecommunication practice for many years.
Since Mr. Bette’s retirement, he has been active as an advisor and coach to several former clients, including some global private equity and alternative investment firms. He serves on several private equity held portfolio company boards. Additionally he is an Adjunct Lecturer at the Department of Management, Organization and Strategy at the Kellogg School of Management at Northwestern University teaching courses on a range topics including strategy, problem solving techniques and managing in professional service firms and problem solving. He has been an active on Chicago non-profits boards.
Mr. Bette holds an MBA from the Harvard Business School and a Doctorate in Mathematics from the University Duisburg, Germany. He graduated from the University Dortmund, Germany with a degree in Mathematics and studied at the Universite Pierre et Marie Curie, Paris with post graduate scholarships from the French and German governments.
Thomas W. “Tim” Lyles
Mr. Lyles is President of Mission City Management, Inc. and MedCare Investment Funds. Mr. Lyles has managed an investment portfolio for over twenty years, including both public and large private companies. He also serves on numerous for-profit and non-profit Boards of Directors. Mr. Lyles’ primary responsibility is President of a private holding company, which oversees both strategic and operational issues for various fund portfolios. Mr. Lyles has helped organize each fund in the MedCare Investment Funds group and has served as President of each fund since 1991. As a founding partner, Mr. Lyles was an active member of management in founding Renal Care Group along with Dr. Jacobson and the late Sam Brooks. Mr. Lyles, through his role as President of MedCare Investment Funds, has founded and established numerous health care companies. From 1984 to 1989, Mr. Lyles was an Attorney with the law firm of Haynes and Boone in Dallas, Texas. During 1986 and 1987, he taught Real Estate Financing at Southern Methodist University in Dallas. From 1983 to 1984, he was appointed a Briefing Attorney for the Chief Justice of the Supreme Court of Texas. In 1983, Mr. Lyles received his J.D., Cum Laude from SMU School of Law. Prior to attending law school, he was employed by KPMG Peat Marwick. Mr. Lyles earned an accounting degree from Texas A & M University, where he graduated Summa Cum Laude in 1979. In addition, Mr. Lyles is a Certified Public Accountant and has written material for the Texas State Bar and has been a speaker for the State Bar of Texas and the Dallas Bar.